Exosomatic miR-1246 Promotes Hepatocellular Carcinoma Progression via FSTL5 and ERK/p38 MAPK Pathway

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Hepatocellular carcinoma (HCC) is a prevalent malignancy with limited targeted therapies.
• The role of microRNA-1246 (miR-1246) in HCC, particularly within exosomes, requires further elucidation.
• Understanding exosome-mediated miR-1246 regulation is crucial for developing novel HCC treatments.

Purpose of the Study:

• To investigate the regulatory role of exosomal microRNA-1246 (miR-1246) in hepatocellular carcinoma (HCC) cell invasion, migration, proliferation, and epithelial-mesenchymal transition (EMT).
• To explore the underlying molecular mechanisms involving FSTL5 and ERK/p38 MAPK signaling pathways.

Main Methods:

• Characterization of exosomes from HepG2 cells using Western blotting, nanoparticle tracking analysis, and transmission electron microscopy.
• Quantification of miR-1246 levels via RT-qPCR and assessment of its functional impact after inhibition.
• Evaluation of HCC cell migration, invasion, proliferation, and EMT following treatment with miR-1246 inhibitor-loaded exosomes.

Main Results:

• Elevated miR-1246 levels were observed in HCC tissues and were more concentrated in exosomes derived from HepG2 cells compared to the cells themselves.
• HCC-derived exosomes significantly promoted cancer cell invasion, migration, proliferation, and EMT.
• Inhibition of exosomal miR-1246 effectively suppressed these oncogenic processes, implicating miR-1246 as a key driver.

Conclusions:

• Tumor-derived exosomal miR-1246 actively promotes HCC cell invasion, EMT, and migration.
• The mechanism involves targeting FSTL5 and modulating the ERK/p38 MAPK signaling pathway.
• Exosomal miR-1246 represents a potential therapeutic target for hepatocellular carcinoma.